×
Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Europe Insomnia Market

ID: MRFR/Pharma/0151-HCR
80 Pages
Rahul Gotadki
October 2025

EMEA Insomnia Market Research Report Information By Types Of Therapy (Pharmacological Therapy and Non-Pharmacological Therapy), By Drug Formulation (Capsules, Tablets and Others), By Type Of Diseases Condition (Poor Quality Of Sleep, Sleep Maintenance and Other) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2035.

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Europe Insomnia Market Infographic
Purchase Options

Europe Insomnia Market Summary

The Europe EMEA Insomnia market is poised for substantial growth, projected to reach 2.09 USD Billion by 2035 from a base of 0.5 USD Billion in 2024.

Key Market Trends & Highlights

EMEA Insomnia Key Trends and Highlights

  • The Europe EMEA Insomnia market is valued at 0.5 USD Billion in 2024 and is expected to grow to 2.09 USD Billion by 2035.
  • The market is anticipated to experience a compound annual growth rate (CAGR) of 13.91% from 2025 to 2035.
  • Increasing awareness of sleep disorders is likely to drive market expansion, contributing to the overall growth.
  • Growing adoption of innovative sleep solutions due to rising health consciousness is a major market driver.

Market Size & Forecast

2024 Market Size 0.5 (USD Billion)
2035 Market Size 2.09 (USD Billion)
CAGR (2025-2035) 13.91%

Major Players

Pfizer Inc. (U.K), Sanofi (France), GlaxoSmithKline Plc. (UK), Astellas (UK), Biocodex S A (France), Neurim (Switzerland), Flynn Pharma (UK), CAD Middle East Pharmaceutical Industries LLC (Saudi Arabia), Tabuk Pharmaceutical (Jordan)

Market Segment Insights

EMEA Insomnia Type Insights

Europe, the Middle East and Africa insomnia market has been segmented on the basis of types of therapy which comprises pharmacological therapy and non-pharmacological therapy. Pharmacological therapy is further segmented into benzodiazepines, non-benzodiazepines, melatonin receptor agonists and other. Non pharmacological treatment are further segmented into relaxation therapy, cognitive behavioural therapy, sleep hygiene education, stimulus control, paradoxical intention and other. 

EMEA Insomnia Drug Formulation Insights

By drug formulation they are segmented as capsules, tablet and others. 

EMEA Insomnia Disease Insights

On the basis of type of disease they are poor quality of sleep, sleep maintenance and other.

Get more detailed insights about Europe Insomnia Market

Key Companies in the Europe Insomnia Market market include

Future Outlook

Europe Insomnia Market Future Outlook

Report Scope

Attribute/MetricDetails
  Market Size  USD 2.09 Billion
  CAGR  13.91%
  Base Year  2022
  Forecast Period  2025-2035
  Historical Data 2021
  Forecast Units  Value (USD Million)
  Report Coverage  Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered  Target Antigen, Application and Region
  Geographies Covered  North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors Pfizer Inc. (U.K), Sanofi (France), GlaxoSmithKline Plc. (UK), Astellas (UK), Biocodex S A (France), Neurim (Switzerland). Others players are  Flynn Pharma (UK) CAD Middle East Pharmaceutical Industries LLC (Saudi Arabia), Tabuk Pharmaceutical (Jordan)
  Key Market Opportunities  Increase in the setups of research & development centers and the inclination of top companies toward the developing countries boost
  Key Market Driversprevalence of cancers is increasing the demand for effective treatment The growth of the obese population

Market Highlights

Author
Rahul Gotadki
Assistant Manager

He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

Leave a Comment

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions